Advertisement

Topics

China YCT International Group, Inc. Company Profile

01:20 EDT 30th May 2017 | BioPortfolio

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use chemical products, ginkgo glycoside products and biological medicines.


News Articles [3107 Associated News Articles listed on BioPortfolio]

BRIEF-China Health Group enters cooperation memorandum

* China Pecc International Eco-Tech Cooperation Committee will support co in local healthcare cooperation projects in Mainland China

Weill Cornell Medicine to Help Plan International Hospital in Shanghai, China

Bolstering its commitment to improving human health and increasing access to quality healthcare worldwide, Weill Cornell Medicine has entered into an agreement with Tahoe Investment Group Co. Ltd. to ...

M&As this week: Sun Moral International (HK), Immuno Holding

Sun Moral International (HK), a subsidiary of Chinese pharmaceutical company Sihuan Pharmaceutical Holdings Group, has acquired the entire equity interest in Ambest Pharmaceutical (China) Company.

UPDATE 1-Valeant to sell Dendreon unit to China's Sanpower for $820 mln

Jan 9 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said its affiliate will sell its Dendreon cancer business to China's Sanpower Group Co Ltd for $819.9 million, as the drugmaker co...

"United Laboratories USLEN" insulin glargin gained experts' recognition and recommendation / Successfully won the tender through bidding in four China provinces and products are to be rolled out gradually

HONG KONG, CHINA -- (Marketwired) -- 05/14/17 -- The United Laboratories International Holdings Limited ("TUL", the "Company" or the "Group") (HKSE: 3933), participated the "Basal Insulin Clinical...

China says U.S. trade orders should respect international rules

China called on the United States to respect international trade rules and improve cooperation and dialogue in reaction to two new orders by U.S. President Donald Trump calling for an investigation in...

Valeant to sell Dendreon unit to China's Sanpower for $819.9 mln

Jan 9 (Reuters) - Valeant Pharmaceuticals International Inc said its affiliate will sell its Dendreon Pharmaceuticals business to China's Sanpower Group Co Ltd for $819.9 million in cash.

BRIEF-China Regenerative Medicine International says Chen Chunguo appointed executive director

Jan 25 (Reuters) - China Regenerative Medicine International Ltd :

PubMed Articles [5877 Associated PubMed Articles listed on BioPortfolio]

Use of the 10-Group Classification System to analyze how the population control policy change in China has affected cesarean delivery.

To analyze the initial effect following the relaxation of China's population control policy on the cesarean delivery (CD) rate using the 10-Group Classification System (TGCS).

Adapting an attention-deficit hyperactivity disorder parent training intervention to different cultural contexts: The experience of implementing the New Forest Parenting Programme in China, Denmark, Hong Kong, Japan, and the United Kingdom.

The New Forest Parenting Programme (NFPP) is a parenting program developed for parents who have a child with attention-deficit hyperactivity disorder (ADHD). It is a manualized program that is deliver...

Epidemiological trends of dengue in mainland China, 2005-2015.

To explore the epidemiological trend of dengue in mainland China.

Efficacy and Safety of 3 Nasal Packing Materials Used After Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A Comparative Study in China.

BACKGROUND This study aimed to investigate the efficacy and safety of 3 nasal packing products (silicone tube, Beschitin-F, and Aquacel1-Ag) after functional endoscopic sinus surgery (FESS) for chroni...

A Case-control Study of Risk Sources for Severe Fever with Thrombocytopenia Syndrome in Hubei Province, China.

Severe fever with thrombocytopenia syndrome (SFTS), an emerging infectious disease caused by a novel bunyavirus, was discovered in rural areas of Central China in 2009.

Clinical Trials [4163 Associated Clinical Trials listed on BioPortfolio]

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

This clinical trial is an international, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial comparing one dose of linaclotide to placebo. Approximately 800 pat...

Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China

Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require...

International Programs Collaborative Studies Coordinating Center

To continue the work of the Collaborative Studies Coordinating Center (CSCC) on international studies in cardiopulmonary disease epidemiology. The work was being performed under bilateral...

A Realworld Study of Acute Respiratory Distress Syndrome in China

ARDS is a critical respiratory disease caused by endogenous and exogenous factors. The mortality of ARDS varies from 30 to 70%. In 2012, a new international diagnostic criterion has been p...

Practice of Mechanical Ventilation in Patients With Severe Brain Injury in China

The mechanical ventilation strategy has changed over years worldwide. Several international researches have been conducted to study the association of the use of mechanical ventilation wit...

Companies [3361 Associated Companies listed on BioPortfolio]

China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic...

China YCT International Group Inc.

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under...

China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ("Yingxia"), is primarily engaged in the development, production and sales of health...

eChinaChem

eChinaChem, Inc., the China subsidiary of Pacific Genuity, Inc. (San Carlos, California), provides an integrated end-to-end solution for international chemical trading with China. Our company offers ...

China Kangtai Cactus Bio-tech Inc.

China Kangtai Cactus Bio-tech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy...

More Information about "China YCT International Group, Inc." on BioPortfolio

We have published hundreds of China YCT International Group, Inc. news stories on BioPortfolio along with dozens of China YCT International Group, Inc. Clinical Trials and PubMed Articles about China YCT International Group, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China YCT International Group, Inc. Companies in our database. You can also find out about relevant China YCT International Group, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record